Mr. Chris Ogden, Consultant Uro-oncologist, MB BS MS FRCSEd FRCSEng FRCSUrol FEBU.
Da Vinci nerve sparing robotic prostate surgery
High intensity focused ultrasound (HIFU) for prostate cancer
Chris Ogden, consultant Uro-oncologist is a pioneer of robotic surgery in the UK and ‘one of the worlds leading robotic surgeons’ (BBC Horizon). He has the longest and largest series of radical robotic prostatectomies in the UK, completing thousands of procedures (Mail on Sunday August 2017). Mr Ogden was recruited to The Royal Marsden in 2006 to set up and lead the robotic prostatectomy program. He was attracted to the hospital as a keen advocate of ‘active surveillance' for prostate cancer, which was invented at the Marsden.
"Chris Ogden - one of the world's leading robotic surgeons" BBC Horizon
Chris Ogden was the first UK urologist to present the UK experience to the fledgling European Robotic Urological Society and the American Urological Society; also presenting the first one hundred, then 500, robotic cases with outcome to the British Urological Society; as well as the only clinical comparison between whole gland HIFU and Robotic prostatectomy, the two novel competing technologies at that time. This comparison showed that whole gland HIFU delivered the perfect trifecta outcome in a third of patients, but that overall robotic surgical removal had the edge.
He has been a part of the development of Focal day case surgery for treating certain forms of prostate cancer, completing the multi centre INDEX study into the effectiveness of focal therapy, published in 2017.
The national AUDIT for radical prostatectomy within British Urology (BAUS) was made public for the first time in 2015. More recently the three year data outcomes for 2015, 2016 and 2017 have been analysed. The data shows that Mr Ogden is one of the few high volume surgeons in robotic prostate surgery (more than 100 cases a year). In this national analysis, he has had no serious complications (Clavian III or above) and zero transfusion rate.
The three year BAUS national Audit data shows that although Mr Ogden's practice encompasses a higher percentage of more aggressive cancer, T3 or above (53% versus the national average of 45.83%), he demonstrates an overall personal unfavourable prostate cancer margin rate of 11.8% compared to the overall national margin rate of 26.3%.
Mr Ogden’s results are equivalent to the best published results of the world leading robotic prostate surgeons: for cancer margins (clearance), urinary continence and sexual function.
Please click the button below to see full BAUS data published in 2018.
Mr Ogden continues to innovate. Over the last year, he teamed up with Dr Kouk of the Cleveland clinic to perform the first Radical Robotic Perineal Prostatectomy in Europe, written up in Urology News at the time. Since, he has performed around twenty cases and he presented his outcomes (the first series in Europe) to ERUS in 2019 and is due to present them to the European Urological Association in July, at the annual congress. He is one of only three surgeons in the world performing the procedure. It has exciting prospects, with the introduction of the latest Da Vinci robot, the SP. The application of his skill in perineal open surgery, learnt as a travelling fellow to Duke University Carolina and developed as a newly appointed consultant, married with thousands of robotics prostatectomies performed give him the potential to improve the outcomes for patients undergoing radical prostatectomy .